Efficient gene transfer into human CD34+ cells by an adenovirus type 35 vector

Area of Science:

• Molecular Biology
• Gene Therapy
• Stem Cell Research

Background:

• Efficient gene transfer into human hematopoietic stem cells (HSCs) is critical for gene therapy and research.
• Adenovirus serotype 5 (Ad5) vectors exhibit low transduction efficiency in HSCs due to limited coxsackievirus and adenovirus receptor (CAR) expression.
• Alternative adenovirus vectors are needed to overcome these limitations.

Purpose of the Study:

• To develop and evaluate a recombinant adenovirus vector based on Ad serotype 35 (Ad35) for enhanced gene transfer into human CD34(+) cells.
• To compare the transduction efficiency of Ad35 vectors with conventional Ad5 and Ad5F35 vectors.

Main Methods:

• Development of a recombinant Ad35-based vector.
• Transduction of human CD34(+) cells with Ad35, Ad5, and Ad5F35 vectors expressing green fluorescent protein (GFP).
• Quantification of transduction efficiency using fluorescence intensity and percentage of GFP-positive cells.

Main Results:

• Ad35 vectors demonstrated significantly higher transduction efficiency in human CD34(+) cells compared to Ad5 vectors.
• Mean fluorescence intensity was 12-76 times higher for Ad35 vectors than Ad5 vectors.
• While Ad35 and Ad5F35 vectors showed similar percentages of transduced cells (53% vs 52%), Ad35 vectors exhibited higher overall gene transfer efficiency.

Conclusions:

• Recombinant Ad35 vectors provide a more efficient method for gene transfer into human CD34(+) cells than Ad5 and Ad5F35 vectors.
• Ad35-based vectors hold significant potential for advancing gene therapy for hematopoietic disorders and facilitating HSC research.